|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Creutzberg CL, van Putten WL, Koper PC,
Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens
LC, van den Bergh AC, van de Steen-Banasik E, et al: Surgery and
postoperative radiotherapy versus surgery alone for patients with
stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC
study group. Post operative radiation therapy in endometrial
carcinoma. Lancet. 355:1404–1411. 2000. View Article : Google Scholar
|
|
3
|
Nout RA, Smit VT, Putter H,
Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik
EM, Mens JW, Slot A, Kroese MC, et al: Vaginal brachytherapy versus
pelvic external beam radiotherapy for patients with endometrial
cancer of high-intermediate risk (PORTEC-2): An open-label,
non-inferiority, randomised trial. Lancet. 375:816–823. 2010.
View Article : Google Scholar
|
|
4
|
Ørtoft G, Hansen ES and Bertelsen K:
Omitting adjuvant radiotherapy in endometrial cancer increases the
rate of locoregional recurrences but has no effect on long-term
survival: The danish endometrial cancer study. Int J Gynecol
Cancer. 23:1429–1437. 2013. View Article : Google Scholar
|
|
5
|
Thomas GM: A role for adjuvant radiation
in clinically early carcinoma of the endometrium? Int J Gynecol
Cancer. 20 (11 Suppl 2):S64–S66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cancer Genome Atlas Research Network, .
Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H,
Robertson AG, Pashtan I, Shen R, et al: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Talhouk A, McConechy MK, Leung S, Li-Chang
HH, Kwon JS, Melnyk N, Yang W, Senz J, Boyd N, Karnezis AN, et al:
A clinically applicable molecular-based classification for
endometrial cancers. Br J Cancer. 113:299–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Talhouk A and McAlpine JN: New
classification of endometrial cancers: The development and
potential applications of genomic-based classification in research
and clinical care. Gynecol Oncol Res Pract. 3:142016. View Article : Google Scholar
|
|
9
|
Talhouk A, McConechy MK, Leung S, Yang W,
Lum A, Senz J, Boyd N, Pike J, Anglesio M, Kwon JS, et al:
Confirmation of ProMisE: A simple, genomics-based clinical
classifier for endometrial cancer. Cancer. 123:802–813. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu AY, Zheng H and Ouyang G: Periostin, a
multifunctional matricellular protein in inflammatory and tumor
microenvironments. Matrix Biol. 37:150–156. 2014. View Article : Google Scholar
|
|
11
|
Woodruff PG, Boushey HA, Dolganov GM,
Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick TP,
Pantoja C, et al: Genome-wide profiling identifies epithelial cell
genes associated with asthma and with treatment response to
corticosteroids. Proc Natl Acad Sci USA. 104:15858–15863. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dorn GW II: Periostin and myocardial
repair, regeneration, and recovery. N Engl J Med. 357:1552–1554.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sasaki H, Dai M, Auclair D, Kaji M, Fukai
I, Kiriyama M, Yamakawa Y, Fujii Y and Chen LB: Serum level of the
periostin, a homologue of an insect cell adhesion molecule, in
thymoma patients. Cancer Lett. 172:37–42. 2001. View Article : Google Scholar
|
|
14
|
Shao R, Bao S, Bai X, Blanchette C,
Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired
expression of periostin by human breast cancers promotes tumor
angiogenesis through up-regulation of vascular endothelial growth
factor receptor 2 expression. Mol Cell Biol. 24:3992–4003. 2004.
View Article : Google Scholar
|
|
15
|
Hiroi H, Momoeda M, Nakazawa F, Koizumi M,
Tsutsumi R, Hosokawa Y, Osuga Y, Yano T, Tsutsumi O and Taketani Y:
Expression and regulation of periostin/OSF-2 gene in rat uterus and
human endometrium. Endocr J. 55:183–189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Creasman WT, Odicino F, Maisonneuve P,
Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY and Pecorelli S:
Carcinoma of the corpus uteri. FIGO 26th annual report on the
results of treatment in gynecological cancer. Int J Gynaecol
Obstet. 95 (Suppl 1):S105–S143. 2006. View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nicholson EM, Greenlee JJ and Hamir AN:
PrPSc detection in formalin-fixed paraffin-embedded tissue by
ELISA. BMC Res Notes. 4:4322011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lindsley A, Snider P, Zhou H, Rogers R,
Wang J, Olaopa M, Kruzynska-Frejtag A, Koushik SV, Lilly B, Burch
JB, et al: Identification and characterization of a novel Schwann
and outflow tract endocardial cushion lineage-restricted periostin
enhancer. Dev Biol. 307:340–355. 2007. View Article : Google Scholar
|
|
21
|
Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu
M, Anderson RM, Rich JN and Wang XF: Periostin potently promotes
metastatic growth of colon cancer by augmenting cell survival via
the Akt/PKB pathway. Cancer Cell. 5:329–339. 2004. View Article : Google Scholar
|
|
22
|
Baril P, Gangeswaran R, Mahon PC, Caulee
K, Kocher HM, Harada T, Zhu M, Kalthoff H, Crnogorac-Jurcevic T and
Lemoine NR: Periostin promotes invasiveness and resistance of
pancreatic cancer cells to hypoxia-induced cell death: Role of the
beta4 integrin and the PI3k pathway. Oncogene. 26:2082–2094. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Michaylira CZ, Wong GS, Miller CG,
Gutierrez CM, Nakagawa H, Hammond R, Klein-Szanto AJ, Lee JS, Kim
SB, Herlyn M, et al: Periostin, a cell adhesion molecule,
facilitates invasion in the tumor microenvironment and annotates a
novel tumor-invasive signature in esophageal cancer. Cancer Res.
70:5281–5292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo W and Yao K: Molecular
characterization and clinical implications of spindle cells in
nasopharyngeal carcinoma: A novel molecule-morphology model of
tumor progression proposed. PLoS One. 8:e831352013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Soltermann A, Tischler V, Arbogast S,
Braun J, Probst-Hensch N, Weder W, Moch H and Kristiansen G:
Prognostic significance of epithelial-mesenchymal and
mesenchymal-epithelial transition protein expression in non-small
cell lung cancer. Clin Cancer Res. 14:7430–7437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seifert GJ: Fascinating fasciclins: A
surprisingly widespread family of proteins that mediate
ınteractions between the cell exterior and the cell surface. Int J
Mol Sci. 19:16282018. View Article : Google Scholar
|
|
27
|
Malanchi I, Santamaria-Martínez A, Susanto
E, Peng H, Lehr HA, Delaloye JF and Huelsken J: Interactions
between cancer stem cells and their niche govern metastatic
colonization. Nature. 481:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin X, Yan M, Zhang J, Wang X, Shen Z, Lv
Z, Li Z, Wei W and Chen W: TGFβ3-mediated induction of periostin
facilitates head and neck cancer growth and is associated with
metastasis. Sci Rep. 6:205872016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Utispan K, Thuwajit P, Abiko Y, Charngkaew
K, Paupairoj A, Chau-in S and Thuwajit C: Gene expression profiling
of cholangiocarcinoma-derived fibroblast reveals alterations
related to tumor progression and indicates periostin as a poor
prognostic marker. Mol Cancer. 9:132010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ryner L, Guan Y, Firestein R, Xiao Y, Choi
Y, Rabe C, Lu S, Fuentes E, Huw LY, Lackner MR, et al: Upregulation
of periostin and reactive stroma ıs associated with primary
chemoresistance and predicts clinical outcomes in epithelial
ovarian cancer. Clin Cancer Res. 21:2941–2951. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sung PL, Jan YH, Lin SC, Huang CC, Lin H,
Wen KC, Chao KC, Lai CR, Wang PH, Chuang CM, et al: Periostin in
tumor microenvironment is associated with poor prognosis and
platinum resistance in epithelial ovarian carcinoma. Oncotarget.
7:4036–4047. 2016. View Article : Google Scholar
|
|
32
|
Hu W, Jin P and Liu W: Periostin
contributes to cisplatin resistance in human non-small cell lung
cancer A549 cells via activation of Stat3 and Akt and upregulation
of survivin. Cell Physiol Biochem. 38:1199–1208. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wong GS, Habibollahi P, Heidari P, Lee JS,
Klein-Szanto AJ, Waldron TJ, Gimotty P, Nakagawa H, Taylor PR, Wang
TC, et al: Optical imaging of periostin enables early endoscopic
detection and characterization of esophageal cancer in mice.
Gastroenterology. 144:294–297. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kyutoku M, Taniyama Y, Katsuragi N,
Shimizu H, Kunugiza Y, Iekushi K, Koibuchi N, Sanada F, Oshita Y
and Morishita R: Role of periostin in cancer progression and
metastasis: Inhibition of breast cancer progression and metastasis
by anti-periostin antibody in a murine. Int J Mol Med. 28:181–186.
2011.PubMed/NCBI
|
